Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effect of once-weekly (OW) dosing of subcutaneous semaglutide (1.0 mg) versus once-daily dosing of oral canagliflozin (300 mg) on glycaemic control in subjects with type 2 diabetes (T2D) on a background treatment of metformin.
Critère d'inclusion
- Diabetes Mellitus, Type 2